Life Science Leader Magazine Supplements

CRO Leadership Awards 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/266911

Contents of this Issue

Navigation

Page 23 of 45

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 22 SERVICES & CAPABILITIES: Comprehensive analytical support for large and small molecules, preformulation through commercial release: MD/MV; development & commercial stability; extractables & leachables; release testing; metabolite/impurity isolation, ID and characterization; bioanalysis; DMPK; plus niche expertise in radiolabeling synthesis and environmental assessments THERAPEUTIC AREAS: A ll therapeutic areas, including those involving high-potency and cytotoxic drugs. "It is an honor to be recognized for the 2014 CRO Leadership Award by our clients. It is validating to see our investments in expertise, talent, and leadership, combined with a strong foundation in quality, service, and capacity, are coming together. Our mission is to be a trusted extension of our client's development team." SERVICES & CAPABILITIES: Acceleration provides support for clinical trials in method development and validation of methods for analysis and release of clinical dosage formulations. Preclinical support is provided in characterization and production of API, formulation support, and tox dose analysis. THERAPEUTIC AREAS: Acceleration supports all therapeutic areas, yet has extensive experience in working with oncolytics, cytoxics, and other highly potent compounds. "We are, once again, honored to be thought of so highly by our peers within the life sciences industry, through the CRO Leadership Awards. Earning awards within the categories of reliability, innovation, productivity, and regulatory is a testament to the dedication and passion of each member of the A cceleration team. Our experienced team strives to find the most efficient solutions for our clients, and to not simply focus on the finish line, yet to ensure the path we take is one that will allow long-term success." SERVICES & CAPABILITIES: Algorithme Pharma provides a unique, full-service offering focused on early stage clinical development. Our services include the design and conduct of Phase I/ IIa clinical trials, large and small molecule bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology, and project management. THERAPEUTIC AREAS: Algorithme Pharma provides research services to the pharmaceuti- cal, generic, and biotechnology industries, with particular expertise in metabolic disease, nephrology, inflammation, hormone therapy, and infectious disease. "Partnering with our clients to get their drug through this critical early stage of drug development is our company focus. It is very rewarding to have these efforts recognized, as we work hard to treat every project with individualized attention, and to provide a personalized and customized service that surpasses our clients' expectations. Our company is continuously looking for ways to improve our customer relationships and our range of services to create even greater value for our sponsors." DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, and Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical, CMC Analytical MAIN SERVICE AREAS: Clinical, Preclinical MAIN SERVICE AREAS: Clinical, Bioanalytical DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2 ) JOHN BUCKSATH president and CEO BRENT TAYLOR CEO CHRIS PERKIN chief executive officer CATEGORIES WON CATEGORIES WON: CATEGORIES WON Algorithme Pharma Laval (Montreal), Quebec, Canada www.algopharm.com +1 450 973 6077 Catherine Konidas, VP Global Business Dev. ckonidas@algopharm.com Acceleration Laboratory Services, Inc Lee's Summit, MO http://accelerationkc.com/ +1 816 525 1150 Rob Poe rpoe@accelerationkc.com Key locations: Greater Kansas City, MO ABC Laboratories Columbia, MO www.abclabs.com +1 800 538 2227 Kristein King kingk@abclabs.com Key locations: Columbia, MO and University of Missouri Discovery Ridge Research Park 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 4 2014 LSL CRO Company Profile Layout That Nice.indd 4 2 / 2 2 / 2 0 1 4 1 : 3 5 : 1 4 P M 2/22/2014 1:35:14 PM

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2014